血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)卵白蛋白偶聯(lián)物
OVA Conjugated Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
Flt1; Fms-Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-like tyrosine kinase 1; Tyrosine-protein kinase receptor FLT
- 編號(hào)CPB818Hu21
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來(lái)源蛋白偶聯(lián)
- 原分子量-
- 緩沖液成份磷酸鹽緩沖液（pH7.4）
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)-
-
應(yīng)用
Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 840 ¥ 2100 ¥ 4200 ¥ 12600 ¥ 31500
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Mass spectrometry
-
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
化學(xué)式
用法
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| EPB818Hu61 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB818Hu01 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPB818Hu62 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB818Hu02 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPB818Hu21 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
| PAB818Hu01 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB818Hu08 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB818Hu81 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB818Hu71 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB818Hu22 | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)單克隆抗體 | WB; IHC; ICC; IP. |
| HEB818Hu | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB818Hu | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB818Hu | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB818Hu | 血管內(nèi)皮生長(zhǎng)因子受體1(VEGFR1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Clinical cardiology | Growth Differentiation Factor 15 and Coronary Collateral Formation [PubMed: 20014173] |
| Microvascular Research | Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle [PubMed: 20937289] |
| Science Alert | Antiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats [Scialert: Source] |
| Acta Biomater | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study [PubMed: 26689470] |
| Naunyn Schmiedebergs Arch Pharmacol | The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis [PubMed: 26269412] |
| Acta Biomaterialia | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study [Pubmed:26689470] |
| Journal?of?Cellular?Physiology | A?Human?3D?In?Vitro?Model?to?Assess?the?Relationship?Between?Osteoporosis?and?Disseminationto?Bone?of?Breast?Cancer?Tumor?Cells. [pubmed:27925188] |
| Oncotarget | Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway. [pubmed:29262624] |
| Placenta | Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery. [pubmed:28962687] |
| Acta?Biomaterialia | Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment [Pubmed: 30445158] |
| Scientific Reports | Association between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea [Pubmed: 31882827] |
| JOURNAL OF DERMATOLOGICAL TREATMENT | Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris [Pubmed: 32043381] |
| FASEB JOURNAL | Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible?… [Pubmed: 33205477] |
| Children (Basel) | sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates [34438609] |
| Oxid Med Cell Longev | Reactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation [Pubmed:35693704] |
留言咨詢
